The DOI matches its Crossref record; 88 of the 90 references it cites were found in a registry or an index.
Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats
Abstract
Bipolar Disorder (BD) is one of the most severe psychiatric disorders. Despite adequate treatment, patients continue to have recurrent mood episodes, residual symptoms, and functional impairment. Some preclinical studies have shown that histone deacetylase inhibitors may act on manic-like behaviors. Neurotrophins have been considered important mediators in the pathophysiology of BD. The present study aims to investigate the effects of lithium (Li), valproate (VPA), and sodium butyrate (SB), an HDAC inhibitor, on BDNF, NGF and GDNF in the brain of rats subjected to an animal model of mania induced by ouabain. Wistar rats received a single ICV injection of ouabain or artificial cerebrospinal fluid. From the day following ICV injection, the rats were treated for 6 days with intraperitoneal injections of saline, Li, VPA or SB twice a day. In the 7th day after ouabain injection, locomotor activity was measured using the open-field test. The BDNF, NGF and GDNF levels were measured in the hippocampus and frontal cortex by sandwich-ELISA. Li, VPA or SB treatments reversed ouabain-related manic-like behavior. Ouabain decreased BDNF, NGF and GDNF levels in hippocampus and frontal cortex of rats. The treatment with Li, VPA or SB reversed these impairment induced by ouabain. In addition, Li, VPA and SB per se increased NGF and GDNF levels in hippocampus of rats. Our data support the notion that neurotrophic factors play a role in BD and in the mechanisms of the action of Li, VPA and SB.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neurotrophic factors, such as nerve growth factor (NGF), glial cell line-derived neurotrophic factor (GDNF), and BDNF that regulate the growth, survival and differentiation of neurons and synapses in the CNS also play important parts in learning and memory and in a range of brain disorders have been also shown to be modulated by SCFAs (120–123).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [121]
In the citing paper
“SCFAs additionally influence neuroplasticity and neurogenesis by modulating neurotrophic factors, including brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and glial cell line-derived neurotrophic factor (GDNF) [149,150].”
From Unraveling the Connections: Eating Issues, Microbiome, and Gastrointestinal Symptoms in Autism Spectrum Disorder (2025) · cites this paper as [149]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I
Glowinski, J., & Iversen, L. L. (1966) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1966.tb09873.x · Cited by 5,436
Yatham, L. N., & Malhi, G. S. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,515
GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons
Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206
Levi‐Montalcini, R., & Angeletti, P. U. (1968) · Physiological Reviews · doi:10.1152/physrev.1968.48.3.534 · Cited by 2,006
Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor.
Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H., & Bonhoeffer, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8856 · Cited by 1,426
Long-Lasting Neurotrophin-Induced Enhancement of Synaptic Transmission in the Adult Hippocampus
Kang, H., & Schuman, E. M. (1995) · Science · doi:10.1126/science.7886457 · Cited by 1,354
NEUROTROPHINS AND SYNAPTIC PLASTICITY
McAllister, A. K., Katz, L. C., & Lo, D. C. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.295 · Cited by 1,337
Geddes, J. R., & Miklowitz, D. J. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60857-0 · Cited by 848
GDNF, NGF and BDNF as Therapeutic Options for Neurodegeneration
Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.004 · Cited by 820
Ernfors, P., Wetmore, C., Olson, L., & Persson, H. (1990) · Neuron · doi:10.1016/0896-6273(90)90090-3 · Cited by 819
Mediation by a CREB Family Transcription Factor of NGF-Dependent Survival of Sympathetic Neurons
Riccio, A., Ahn, S., Davenport, C. M., Blendy, J. A., & Ginty, D. D. (1999) · Science · doi:10.1126/science.286.5448.2358 · Cited by 802
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Leon, A. C., Solomon, D. A., Coryell, W., Maser, J. D., & Keller, M. B. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.12.1322 · Cited by 577 · cited 1×
“In addition, BD patients have psychotic symptoms, impaired functioning and compromised quality of life (Judd et al., 2005; Michalak et al., 2011; Subramaniam et al., 2013).”
BackgroundLong Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression
Chen, R., & Chuang, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6039 · Cited by 466
Hoffer, B. J., Hoffman, A. F., Bowenkamp, K., Huettl, P. F., Hudson, J., Martin, D., Lin, L.-F. H., & Gerhardt, G. A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90218-6 · Cited by 453
Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder
Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404
Cunha, A. B. M., Frey, B. N., Andreazza, A. C., Goi, J. D., Rosa, A. R., Gonçalves, C. A., Santin, A. M. P., & Kapczinski, F. P. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.085 · Cited by 391
Fernandes, B. S., Gama, C. S., Maria Ceresér, K., Yatham, L. N., Fries, G. R., Colpo, G., de Lucena, D., Kunz, M., Gomes, F. A., & Kapczinski, F. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.03.002 · Cited by 389
Fukumoto, T., Morinobu, S., Okamoto, Y., Kagaya, A., & Yamawaki, S. (2001) · Psychopharmacology · doi:10.1007/s002130100871 · Cited by 377
Yasuda, S., Liang, M.-H., Marinova, Z., Yahyavi, A., & Chuang, D.-M. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002099 · Cited by 358
The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain
Kim, H. J., Leeds, P., & Chuang, D. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06212.x · Cited by 332
Absolute requirement of GDNF for adult catecholaminergic neuron survival
Pascual, A., Hidalgo‐Figueroa, M., Piruat, J. I., Pintado, C. O., Gómez-Díaz, R., & López‐Barneo, J. (2008) · Nature Neuroscience · doi:10.1038/nn.2136 · Cited by 332
Wu, X., Chen, P. S., Dallas, S., Wilson, B. C., Block, M. L., Wang, C.-C., Kinyamu, H. K., Lu, N. Z., Gao, X., Leng, Y., et al. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009024 · Cited by 318
Moseley, A. E., Williams, M. T., Schaefer, T. L., Bohanan, C. S., Neumann, J. C., Behbehani, M. M., Vorhees, C. V., & Lingrel, J. B. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4464-06.2007 · Cited by 288
Estrogen–BDNF interactions: Implications for neurodegenerative diseases
Sohrabji, F., & Lewis, D. K. (2006) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.09.003 · Cited by 284
Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
Licciardi, P. V., Ververis, Hiong, & Karagiannis, T. C. (2013) · Biologics · doi:10.2147/btt.s29965 · Cited by 282
Cellular Plasticity Cascades: Targets for the Development of Novel Therapeutics for Bipolar Disorder
Zarate, C. A., Singh, J. B., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.021 · Cited by 275
Tomac, A., Widenfalk, J., Lin, L., Kohno, T., Ebendal, T., Hoffer, B. J., & Olson, L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8274 · Cited by 258
Gray, J. D., Milner, T. A., & McEwen, B. S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.034 · Cited by 250
Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania
Frey, B. N., Andreazza, A. C., Ceresér, K. M. M., Martins, M. R., Valvassori, S. S., Réus, G. Z., Quevedo, J., & Kapczinski, F. P. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.01.002 · Cited by 239
Manji, H. K., Moore, G. J., & Chen, G. (2000) · PubMed · Cited by 232
Scheiner‐Bobis, G. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02909.x · Cited by 209
The Na,K-ATPase hypothesis for bipolar illness
El‐Mallakh, R. S., & Wyatt, R. J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00201-d · Cited by 204
Association of valproate‐induced teratogenesis with histone deacetylase inhibition in vivo
Gurvich, N., Berman, M. G., Wittner, B. S., Gentleman, R. C., Klein, P. S., & Green, J. B. A. (2005) · The FASEB Journal · doi:10.1096/fj.04-3425fje · Cited by 191
Rizzo, L. B., Costa, L. G., Mansur, R. B., Swardfager, W., Belangero, S. I., Grassi-Oliveira, R., McIntyre, R. S., Bauer, M. E., & Brietzke, E. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.004 · Cited by 183
Divalproex in the treatment of bipolar depression: a placebo-controlled study
Davis, L. L., Bartolucci, A., & Petty, F. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.09.009 · Cited by 181
Basic neurochemistry : principles of molecular, cellular and medical neurobiology
Brady, S. T., Siegel, G. J., Albers, R. W., & Price, D. L. (2012) · Cited by 171
The NGF saga: From animal models of psychosocial stress to stress-related psychopathology
Cirulli, F., & Alleva, E. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.002 · Cited by 166
Granholm, A., Reyland, M. E., Albeck, D. S., Sanders, L., Gerhardt, G. A., Hoernig, G. R., Shen, L., Westphal, H., & Hoffer, B. J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03182.2000 · Cited by 160
Neurotrophins and Synaptic Plasticity
Gómez-Palacio-Schjetnan, A., & Escobar, M. L. (2013) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_231 · Cited by 158
Perspectives for the development of animal models of bipolar disorder
Machado-Vieira, R., Kapczinski, F., & Soares, J. C. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.10.015 · Cited by 158
Angelucci, F., Aloe, L., Jiménez-Vasquez, P., & Mathé, A. A. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003468 · Cited by 157
Predictive animal models of mania: hits, misses and future directions
Young, J. W., Henry, B. L., & Geyer, M. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01318.x · Cited by 136
Pizzorusso, T., Ratto, G. M., Putignano, E., & Maffei, L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02809.2000 · Cited by 132
Effects of lithium therapy on Na+–K+-ATPase activity and lipid peroxidation in bipolar disorder
Banerjee, U., Dasgupta, A., Rout, J. K., & Singh, O. P. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.006 · Cited by 128
Vaillend, C., Mason, S. E., Cuttle, M. F., & Alger, B. E. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00244.2002 · Cited by 126
Intracerebroventricular administration of ouabain as a model of mania in rats
El‐Mallakh, R. S., El-Masri, M. A., Huff, M. O., Li, X., Decker, S., & Levy, R. S. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00053.x · Cited by 122
Histone Deacetylases and Mood Disorders: Epigenetic Programming in Gene‐Environment Interactions
Machado‐Vieira, R., Ibrahim, L. A., & Zarate, C. A. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00203.x · Cited by 121
Staging and Neuroprogression in Bipolar Disorder: A Systematic Review of the Literature
Gama, C. S., Kunz, M., Magalhães, P. V. D. S., & Kapczinski, F. P. (2013) · Brazilian Journal of Psychiatry · doi:10.1016/j.rbp.2012.09.001 · Cited by 112
Neuronal apoptosis induced by histone deacetylase inhibitors
Salminen, A., Tapiola, T., Korhonen, P., & Suuronen, T. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00210-1 · Cited by 109
Boger, H., Middaugh, L. D., Huang, P., Zaman, V., SMITH, A., Hoffer, B. J., Tomac, A., & Granholm, A. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.06.006 · Cited by 108
Jornada, L. K., Moretti, M., Valvassori, S. S., Ferreira, C. L., Padilha, P. T., Arent, C. O., Fries, G. R., Kapczinski, F., & Quevedo, J. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.11.002 · Cited by 107
Jornada, L. K., Valvassori, S. S., Steckert, A. V., Moretti, M., Mina, F., Ferreira, C. L., Arent, C. O., Dal‐Pizzol, F., & Quevedo, J. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.05.011 · Cited by 92
An animal model for mania: Preliminary results
El‐Mallakh, R. S., Harrison, L. T., Li, R., Changaris, D. G., & Levy, R. S. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00123-d · Cited by 84
Michalak, E. E., Livingston, J., Hole, R., Suto, M., Hale, S., & Haddock, C. (2011) · Chronic Illness · doi:10.1177/1742395310395959 · Cited by 84
Behavioral and neurochemical effects of sodium butyrate in an animal model of mania
Moretti, M., Valvassori, S. S., Varela, R. B., Ferreira, C. L., Rochi, N., Benedet, J., Scaini, G., Kapczinski, F., Streck, E. L., Zugno, A. I., et al. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32834d0f1b · Cited by 84 · cited 1×
“Indeed, in recent studies from our laboratory research it was reported that SB treatment prevented and reversed the manic-like behaviors induced by ouabain and Damphetamine (Arent et al., 2011; Moretti et al., 2011; Resende et al., 2013; Stertz et al., 2014; Valvassori et al., 2013; Steckert et al., 2013).”
BackgroundSelf-citationRiegel, R. E., Valvassori, S. S., Elias, G. A., Réus, G. Z., Steckert, A. V., de Souza, B., Petronilho, F. C., Gavioli, E. C., Dal‐Pizzol, F., & Quevedo, J. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.05.003 · Cited by 75
Circulating levels of GDNF in bipolar disorder
Barbosa, I. G., Huguet, R. B., Sousa, L. P., Abreu, M. N. S., Rocha, N. P., Bauer, M. E., Carvalho, L. A., & Teixeira, A. L. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.031 · Cited by 71
Na,K-ATPase signal transduction triggers CREB activation and dendritic growth
Desfrere, L., Karlsson, M., Hiyoshi, H., Malmersjö, S., Nanou, E., Estrada, M., Miyakawa, A., Lagercrantz, H., Manira, A. E., Lal, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809253106 · Cited by 70
Hellweg, R., Lang, U. E., Nagel, M., & Baumgartner, A. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001042 · Cited by 70
McCarren, M., & Alger, B. E. (1987) · Journal of Neurophysiology · doi:10.1152/jn.1987.57.2.496 · Cited by 66
Mimicking human bipolar ion dysregulation models mania in rats
Herman, L., Hougland, T., & El‐Mallakh, R. S. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.04.001 · Cited by 66
Resende, W. R., Valvassori, S. S., Réus, G. Z., Varela, R. B., Arent, C. O., Ribeiro, K. F., Bavaresco, D. V., Andersen, M. L., Zugno, A. I., & Quevedo, J. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32836546fc · Cited by 65
Self-citationGrowth factors in synaptic function
Poon, V. Y., Choi, S., & Park, M. (2013) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2013.00006 · Cited by 65
Keck, P. E., McElroy, S. L., & Arnold, L. M. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70334-5 · Cited by 65
Impaired nerve growth factor homeostasis in patients with bipolar disorder
Barbosa, I. G., Huguet, R. B., Neves, F. S., Reis, H. J., Bauer, M. E., Janka, Z., Palotás, A., & Teixeira, A. L. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.518629 · Cited by 61
Walz, J. C., Frey, B. N., Andreazza, A. C., Ceresér, K. M. M., de Cacilhas, A. A., Valvassori, S. S., Quevedo, J., & Kapczinski, F. P. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.03.005 · Cited by 58
Genes Are Often Sheltered from the Global Histone Hyperacetylation Induced by HDAC Inhibitors
Halsall, J., Gupta, V., O'Neill, L. P., Turner, B. M., & Nightingale, K. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033453 · Cited by 57 · cited 1×
“It is known that HDAC inhibitors, including SB and VPA, alter the genic transcription, including neurotrophins gene's (Fukumoto et al., 2001; Yasuda et al., 2009; Halsall et al., 2012).”
BackgroundPersistent Hyperactivity Following a Single Intracerebroventricular Dose of Ouabain
Ruktanonchai, D., El-Mallakh, R. S., Li, R., & Levy, R. S. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(97)00457-5 · Cited by 56
Hisaoka, K., Maeda, N., Okada‐Tsuchioka, M., & Takebayashi, M. (2007) · Brain Research · doi:10.1016/j.brainres.2007.12.019 · Cited by 54
Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania
Recco, K. C. C., Valvassori, S. S., Varela, R. B., Resende, W. R., Arent, C. O., Vitto, M. F., da Luz, G., de Souza, C. T., & Quevedo, J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112463124 · Cited by 50
Subramaniam, M., Abdin, E., Vaingankar, J. A., Nan, L., Heng, D., McCrone, P., & Chong, S. A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.11.033 · Cited by 49
Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania
Frey, B. N., Andreazza, A. C., Rosa, A. R., Martins, M. R., Valvassori, S. S., Réus, G. Z., Hatch, J. P., Quevedo, J., & Kapczinski, F. P. (2006) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000205013.59455.09 · Cited by 46
Neuroanatomical Profile of Antimaniac Effects of Histone Deacetylases Inhibitors
Arent, C. O., Valvassori, S. S., Fries, G. R., Stertz, L., Ferreira, C. L., Lopes-Borges, J., Mariot, E., Varela, R. B., Ornell, F. R., Kapczinski, F. P., et al. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8178-0 · Cited by 45
Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
Keck, P. E., & McElroy, S. L. (2002) · PubMed · Cited by 44
Stertz, L., Fries, G. R., de Aguiar, B. W., Pfaffenseller, B., Valvassori, S. S., Gubert, C., Ferreira, C. L., Moretti, M., Ceresér, K. M. M., Kauer‐Sant’Anna, M., et al. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1094 · Cited by 41
Morita, K., Gotohda, T., Arimochi, H., Lee, M., & Her, S. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22072 · Cited by 35
Valvassori, S. S., Calixto, K. V., Budni, J., Resende, W. R., Varela, R. B., Freitas, K. V., Gonçalves, C. L., STRECK, E. L., & Quevedo, J. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1056-3 · Cited by 34
Morita, K., & Her, S. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9034-6 · Cited by 34
Johnstone, V., & Raymond, C. R. (2013) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2013.00001 · Cited by 32
Steckert, A. V., Valvassori, S. S., Varela, R. B., Mina, F., Resende, W. R., Bavaresco, D. V., Ornell, F. R., Dal‐Pizzol, F., & Quevedo, J. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.02.001 · Cited by 31
Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease
Blanco, G. V., & Wallace, D. P. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00248.2013 · Cited by 30
Johar, K., Priya, A., & Wong‐Riley, M. T. T. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12415 · Cited by 29
Nishino, S., Ohtomo, K., Numata, Y., Sato, T., Nakahata, N., & Kurita, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.07.008 · Cited by 25
Endobain E, a brain Na+, K+-ATPase inhibitor, decreases norepinephrine uptake in rat hypothalamus
Vatta, M. S., Peña, C., Fernández, B. E., & Arnaiz, G. R. D. L. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.09.004 · Cited by 23
[Neurotrophic factors: basis for their clinical application].
Morís, G., & Vega, J. A. (2003) · PubMed · Cited by 22
Huff, M. O., Li, X., Ginns, E. I., & El‐Mallakh, R. S. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.09.018 · Cited by 18
Sui, L., Song, X.-J., Ren, J., Ju, L.-H., & Wang, Y. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-0973-5 · Cited by 15
Cited by
Sorted by citations
The role of short-chain fatty acids in microbiota–gut–brain communication
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0157-3 · Cited by 3,357
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00025 · Cited by 3,043
Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?
Bourassa, M. W., Alim, I., Bultman, S. J., & Ratan, R. R. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.009 · Cited by 667
Sun, J., Xu, J., Ling, Y., Wang, F., Gong, T., Yang, C., Ye, S., Ye, K., Wei, D., Song, Z., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0525-3 · Cited by 532
Mailing, L. J., Allen, J. M., Buford, T. W., Fields, C. J., & Woods, J. A. (2019) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000183 · Cited by 521
Metadata
- Authors
- Varela, R. B., Valvassori, S. S., Lopes-Borges, J., Mariot, E., Dal-Pont, G. C., Amboni, R. T., Bianchini, G., & Quevedo, J.
- Affiliations
- Universidade do Extremo Sul Catarinense (BR)
- Venue
- Journal of Psychiatric Research
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 61
- Pages
- 114-121
- ISSN
- 0022-3956 (ISSN-L)
- OpenAlex
- W2068078801
- Cited by
- 115
- References
- 90
- Citations by year
- 2026: 7 · 2025: 16 · 2024: 12 · 2023: 12 · 2022: 12 · 2021: 13 · 2020: 9 · 2019: 9 · 2018: 8 · 2017: 6 · 2016: 8 · 2015: 3
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Psychiatric Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Universidade do Extremo Sul Catarinense
- Instituto Mente e Cérebro - Neurociência
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- sodium butyrate, histone deacetylase inhibitors, bipolar disorder, mania, ouabain, hyperlocomotion, lithium, valproic acid, brain-derived neurotrophic factor, nerve growth factor, glial cell line-derived neurotrophic factor, neurotrophic factors, hippocampus, frontal cortex, mood stabilizers
- MeSH terms
- Affect, Animals, Bipolar Disorder, Disease Models, Animal, Hippocampus, Histamine Antagonists, Locomotion, Male, Motor Activity, Ouabain, Valproic Acid, Treatment Outcome, Rats, Wistar, Prefrontal Cortex, Lithium Compounds, Antimanic Agents, Brain-Derived Neurotrophic Factor, Butyric Acid, Nerve Growth Factor, Glial Cell Line-Derived Neurotrophic Factor, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review